Cyclooxygenase and neuroinflammation in Parkinson's disease neurodegeneration.
Cyclooxygenase (COX) expression in the brain is associated with pro-inflammatory activities, which are instrumental in neurodegenerative processes such as Parkinson's disease (PD). It is discussed that drugs with the capacity to rescue dopaminergic neurons from microglia toxicity and neuroinflammatory processes may result in an amelioration of parkinsonian symptoms by delaying the onset or slowing progression. This article reviews the involvement of COX in neuroinflammation, specifically focussing at the role of selective COX-2 inhibition in neuroinflammation and neurodegeneration in Parkinson's disease.
Bartels
Anna L
AL
Dept. of Neurology, University Medical Centre Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands. a.l.bartels@neuro.umcg.nl
Leenders
Klaus L
KL
J Neuroinflammation. 2008 May 19;5:17
18489773
J Neurosci. 2004 Jan 7;24(1):257-68
14715958
Mol Cell Neurosci. 2000 Dec;16(6):724-39
11124893
Brain Res Mol Brain Res. 2003 Nov 26;119(2):213-5
14625089
Annu Rev Biochem. 2000;69:145-82
10966456
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13926-31
12242329
J Clin Neurosci. 2008 May;15(5):576-7
18343119
Nat Med. 2000 Feb;6(2):137-8
10655096
Neurology. 1988 Aug;38(8):1285-91
3399080
Neurobiol Dis. 2008 Feb;29(2):232-41
17920902
Neurology. 1996 Dec;47(6 Suppl 3):S161-70
8959985
Neurosci Lett. 2002 Sep 6;329(3):354-8
12183047
Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2317-21
8637870
J Neurol. 2000 Apr;247 Suppl 2:II3-10
10991663
Neuroreport. 2001 Mar 26;12(4):839-43
11277593
Parkinsonism Relat Disord. 2010 Jan;16(1):57-9
19487152
J Neurosci Res. 2005 Jul 1;81(1):121-31
15931668
Neurosci Lett. 2008 May 9;436(2):205-9
18403118
J Neuroinflammation. 2004 May 17;1(1):6
15285796
Neuron. 1993 Aug;11(2):371-86
8352945
J Nucl Med. 2007 Apr;48(4):573-81
17401094
Nucl Med Biol. 2008 May;35(4):459-66
18482683
J Neuroinflammation. 2006 Mar 27;3:6
16566823
Glia. 2007 Nov 1;55(14):1459-68
17680643
Ann Neurol. 2005 Feb;57(2):168-75
15668962
Mol Neurobiol. 2004 Apr;29(2):197-212
15126686
Arch Neurol. 2003 Aug;60(8):1059-64
12925360
Mov Disord. 2003 Feb;18(2):121-9
12539204
Ann Neurol. 2005 Dec;58(6):963-7
16240369
Curr Drug Saf. 2006 Aug;1(3):223-5
18690932
Brain Res Brain Res Rev. 2005 Apr;48(2):251-6
15850664
J Neurochem. 2006 Feb;96(3):706-18
16405514
Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5473-8
12702778
Nat Neurosci. 2001 Jul;4(7):702-10
11426226
J Neurochem. 2007 Mar;100(5):1375-86
17254027
Eur J Neurosci. 2003 Jun;17(11):2438-46
12814375
Neurology. 2006 Apr 11;66(7):1097-9
16606925
Mol Pharmacol. 2008 May;73(5):1444-53
18094072
J Comp Neurol. 1995 May 1;355(2):296-315
7608344
Neuroimage. 2008 Feb 1;39(3):1289-98
18024084
N Engl J Med. 2000 Nov 23;343(21):1520-8, 2 p following 1528
11087881
Neurology. 2006 Aug 8;67(3):494-6
16894114
J Neurosci. 2000 Jan 15;20(2):763-70
10632605
J Neurochem. 2004 Jan;88(2):494-501
14690537
Neuroscience. 2000;95(2):425-32
10658622
J Neural Transm (Vienna). 2008 Jul;115(7):1001-9
18265929
Arch Neurol. 2007 Apr;64(4):576-80
17420321
Acta Neuropathol. 2007 Oct;114(4):419-24
17639428
Brain Res. 2003 Feb 28;964(2):288-94
12576189
JAMA. 2000 Sep 13;284(10):1247-55
10979111
Brain Res. 1999 Jun 5;830(2):226-36
10366679
Learn Mem. 2002 Jan-Feb;9(1):41-7
11917005
FASEB J. 2005 Jul;19(9):1134-6
15845609
J Neuropathol Exp Neurol. 2004 Sep;63(9):901-10
15453089
Neurology. 2007 Nov 6;69(19):1836-42
17984451
Trends Pharmacol Sci. 2009 Apr;30(4):174-81
19269697
J Cereb Blood Flow Metab. 2007 Mar;27(3):545-51
16820798
BioDrugs. 2001;15(1):1-9
11437671
Mol Imaging Biol. 2009 Nov-Dec;11(6):386-98
19330384
Mov Disord. 2006 Jul;21(7):964-9
16550541
Ann Pharmacother. 2005 Jul-Aug;39(7-8):1249-59
15956235
Neurobiol Dis. 2006 Feb;21(2):404-12
16182554